Dr. Reddy's Laboratories Ltd
 
 
 
 
公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
公司地址 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
電話號碼 +91 4049002900
傳真號碼 +91 4049002999
公司網頁 https://www.drreddys.com
員工數量 27811
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Jayanth Sridhar Global Head, Biologics INR 33.49M 06/06/2025
Mr. Patrick Aghanian Head, Generics Europe and Consumer Health INR 92.64M 06/06/2025
Mr. M V Narasimham Chief Financial Officer INR 46.54M 06/06/2025
Mr. Sushrut Kulkarni Global Head of Integrated Product Development Organisation INR 54.37M 06/06/2025
Mr. Deepak Sapra Global Head, Pharmaceutical Services and Active Ingredients INR 44.90M 06/06/2025
Ms. Archana Bhaskar Chief Human Resource Officer INR 59.12M 06/06/2025
Mr. Sanjay Sharma Global Head, Manufacturing INR 62.69M 06/06/2025
Mr. Milan Kalawadia Chief Executive Officer, North America Generics INR 72.17M 06/06/2025
Mr. Erez Israeli Chief Executive Officer INR 174.72M 06/06/2025
Mr. M. V. Ramana Chief Executive Officer, Branded Markets, India and Emerging Countries INR 76.89M 06/06/2025
Mr. G.V. Prasad Co-Chairman of the Board and Managing Director -- 06/06/2025
Mr. Krishna Venkatesh Global Head, Quality and Pharmacovigilance INR 34.09M 06/06/2025
Mr. Phani Mitra B Chief Digital and Information Officer INR 31.76M 06/06/2025
 
董事會成員
董事會 職務 更新日期
Ms. Penny Wan Independent Director 06/06/2025
Dr. K. P. Krishnan Independent Director 06/06/2025
Mr. Arun M. Kumar Independent Director 06/06/2025
Dr. Claudio Albrecht Independent Director 06/06/2025
Dr. Alpna Seth, PhD Independent Director 06/06/2025
Ms. Shikha Sanjaya Sharma Independent Director 06/06/2025
Mr. K. Satish Reddy Co-Chairman of the Board 06/06/2025
Mr. G.V. Prasad Co-Chairman of the Board and Managing Director 06/06/2025
Mr. Leo Puri Independent Director 06/06/2025
Mr. Sanjiv Mehta Independent Director 06/06/2025
 
所屬ETF (更新日期: 07/03/2026 03:12)
代號 名稱 佔比% 持有日期
AVEMAvantis Emerging Markets Equity ETF0.19%28/02/2026
SPEMState Street® SPDR® Portfolio EM ETF0.18%27/02/2026
DFAEDimensional Emerging Core Equity Mkt ETF0.05%27/02/2026
DFEMDimensional Emerging Markets Cr Eq 2 ETF0.04%27/02/2026
VEUVanguard FTSE All-Wld ex-US ETF0.04%31/01/2026
FNIFirst Trust Chindia ETF0.03%29/12/2022
DFAXDimensional World ex US Core Eq 2 ETF0.03%27/02/2026
DFEVDimensional Emerging Markets Value ETF0.03%27/02/2026
EELVInvesco S&P Emerging Markets Low Vol ETF0.02%27/02/2026
CWIState Street® SPDR® MSCI ACWI ex-US ETF0.01%27/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.01%27/02/2026
EMEQNomura Focused Emerging Mrkts Eq ETF0.01%27/02/2026
EDOGALPS Emerging Sector Dividend Dogs ETF0.01%28/02/2026
KOMPStt Strt®SPDR®S&PKenshoNwEcosComposETF0.01%27/02/2026
DFSEDimensional Emerging Mrkts Sstby Cr 1ETF0.004%27/02/2026
APIEActivePassive International Equity ETF0.004%27/02/2026
AVXCAvantis Emerging Markets Ex-Chn Eq ETF0.003%28/02/2026
DEXCDimensional Em Mkts ex China Cr Eq ETF0.003%27/02/2026
NSINational Security Emerging Mkts Idx ETF0.002%27/02/2026
ROAMHartford Multifactor Emerging Mkts ETF0.002%28/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.